Polymorphism in serotonin transporter gene associated with susceptibility to major depression

Lancet

Volumn 347, Issue 9003, 1996, Pages 731-733

  Ogilvie, Alan D ^a   Battersby, Sharon ^a   Bubb, Vivien J ^b   Fink, George ^a   Harmar, Anthony J ^a   Goodwin, Guy M ^a   Smith, C A Dale ^b  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ADULT; AFFECTIVE NEUROSIS; ALLELE; ARTICLE; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RISK; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0029939169     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90079-3     Document Type: Article

References (15)

1. Anderson IM, Tomenson BM. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238-49.
2. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localisation. Proc Natl Acad Sci USA 1993; 90: 2542-46.
3. Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin (5-HT) uptake site: identity with the brain 5-HT transporter. J Neurochem 1993; 60: 2319-22.
4. Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 1995; 37: 215-23.
5. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL. Organisation of the human serotonin transporter gene. J Neural Trans 1994; 95: 157-62.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
7. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773-82.
8. Endicott J, Spitzer RL. A diagnostic interview - the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-44.
9. Hudson JI, Pope HG. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology. Am J Psychiatry 1990; 147: 552-64.
10. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375-77.
11. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40: 288-95.
12. Boyer WF, Feighner JP. The serotonin hypothesis: necessary but not sufficient. In: Feighner JP, Boyer WF, eds. Selective serotinin re-uptake inhibitors. Chichester: John Wiley & Sons Ltd, 1991: 71-80.
13. Goltsov AA, Eisensmith RC, Konecki DS, LichterKonecki U, Woo SL. Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 1992; 51: 627-36.
14. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9: 284-92.
15. Lucassen AM, Screaton GR, Julier C, Elliott TJ, Lathrop M, Bell JI. Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype. Hum Mol Genet 1995; 4: 501-06.